HPV Highly Resistant to Standard Medical Cleaning Processes
Journal of Antimicrobial Chemotherapy.
Researchers introduced particles of the HPV 16 strain to 11 common clinical disinfectants used as sterilizers in medical facilities. According to the National Cancer Institute, HPV 16 is one of two HPV strains that cause approximately 70 percent of all cervical cancers. Approximately 85 percent of all anal cancers are caused by HPV 16.
They found the virus to be resistant to glutaraldehyde and ortho-phthalaldehyde.
Researchers suggest disinfectant policy changes are needed to address the highly-resistant virus.
More Articles on Infection Control:
CLABSI Rates Decrease With Presence of Unit Quality Nurse
Decision-Making, Lack of Knowledge Tank Hand Hygiene Compliance
HAI Transmission Through Clothing: 6 Ways to Reduce
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- How Will Healthcare Reform Affect Managed Care Contracting?
- Missouri Ambulatory Surgery Center Association Elects Sandi Baber to Board
- 4 Keys to a Clinically Integrated Supply Chain
- It's Go Time: The Final Preparations for ICD-10
- Kenny Hancock of Meridian Surgical Partners to Speak at Becker's June Conference